Precision Medicine, Artificial Intelligence, and Genomic Markers in Urology. Do we need to Tailor our Clinical Practice?
urol. colomb. (Bogotá. En línea); 29 (3), 2020
Precision medicine plays a key role in urological oncology practice nowadays, with the breakthrough of the poly (ADP-ribose) polymerase inhibitors (PARPi), which play a critical role in different DNA damage repair (DDR) pathways, the immune checkpoint inhibitors, the genomic expression profiles and curre...
ADN, Adenosina Difosfato Ribosa, Anticuerpos Monoclonales, Biomarcadores, Carcinoma, Desarrollo Tecnológico, Fibroblastos, Genómica, Inhibidores de Puntos de Control Inmunológico, Inteligencia Artificial, Investigación Biomédica, Medicina de Precisión, Neoplasias Urológicas, Poli Adenosina Difosfato Ribosa, Receptores de Factores de Crecimiento, Receptores de Factores de Crecimiento de Fibroblastos